Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The future of home oxygen therapy

Holland, Anne E ; Krishnan, Jerry A ; Lacasse, Yves ; Gomes, Humberto ; Björklund, Filip LU orcid ; Casaburi, Richard ; de Andrade, Joao ; Eakin, Michelle N ; Hui, David and Jacobs, Susan S , et al. (2026) In European respiratory review : an official journal of the European Respiratory Society 35(181).
Abstract

Home oxygen therapy is a well-accepted treatment for advanced respiratory disease; however, there are substantial evidence gaps and implementation challenges. The patient experience varies widely; oxygen therapy devices are often poorly matched to patient needs; and adherence is suboptimal. Recent clinical trials have failed to demonstrate positive outcomes of home oxygen therapy across a range of indications and patient groups, raising new questions regarding which patients will benefit. We convened a home oxygen therapy summit, bringing together experts in the fields of hypoxia biology, biomarkers, home oxygen therapy, behavioural science, and clinical trials, to identify the critical steps necessary to advance the science and... (More)

Home oxygen therapy is a well-accepted treatment for advanced respiratory disease; however, there are substantial evidence gaps and implementation challenges. The patient experience varies widely; oxygen therapy devices are often poorly matched to patient needs; and adherence is suboptimal. Recent clinical trials have failed to demonstrate positive outcomes of home oxygen therapy across a range of indications and patient groups, raising new questions regarding which patients will benefit. We convened a home oxygen therapy summit, bringing together experts in the fields of hypoxia biology, biomarkers, home oxygen therapy, behavioural science, and clinical trials, to identify the critical steps necessary to advance the science and practice of home oxygen therapy. Prescription of oxygen therapy depends on identification of hypoxaemia, with or without evidence of end-organ dysfunction. However, this does not acknowledge that hypoxaemia does not always yield hypoxia, and ignores adaptation to hypoxia. There is a pressing need for a hypoxia biomarker that is sensitive and specific, reflects the mechanisms of adaptation and maladaptation to chronic hypoxia, and is responsive to change with supplemental oxygen. Advances in research and clinical care will require more "usable" devices that meet the needs of patients and provide value for payers. Optimising oxygen devices will require new technologies with greater portability and greater capacity for oxygen delivery. Registry-based clinical trials may allow measurement of long-term outcomes and identification of patients most likely to benefit from oxygen therapy. Collaborations between patients, clinicians, researchers, payers and industry will be critical to drive this field forward.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Humans, Oxygen Inhalation Therapy/trends, Home Care Services/trends, Treatment Outcome, Hypoxia/therapy, Lung/physiopathology, Forecasting, Biomarkers/blood
in
European respiratory review : an official journal of the European Respiratory Society
volume
35
issue
181
article number
260144
publisher
European Respiratory Society
external identifiers
  • pmid:42613080
ISSN
0905-9180
DOI
10.1183/16000617.0144-2026
language
English
LU publication?
yes
additional info
Copyright ©The authors 2026.
id
4bb650c0-27c4-4874-a0a8-77e9494e2f18
date added to LUP
2026-08-19 15:31:56
date last changed
2026-08-19 15:57:38
@article{4bb650c0-27c4-4874-a0a8-77e9494e2f18,
  abstract     = {{<p>Home oxygen therapy is a well-accepted treatment for advanced respiratory disease; however, there are substantial evidence gaps and implementation challenges. The patient experience varies widely; oxygen therapy devices are often poorly matched to patient needs; and adherence is suboptimal. Recent clinical trials have failed to demonstrate positive outcomes of home oxygen therapy across a range of indications and patient groups, raising new questions regarding which patients will benefit. We convened a home oxygen therapy summit, bringing together experts in the fields of hypoxia biology, biomarkers, home oxygen therapy, behavioural science, and clinical trials, to identify the critical steps necessary to advance the science and practice of home oxygen therapy. Prescription of oxygen therapy depends on identification of hypoxaemia, with or without evidence of end-organ dysfunction. However, this does not acknowledge that hypoxaemia does not always yield hypoxia, and ignores adaptation to hypoxia. There is a pressing need for a hypoxia biomarker that is sensitive and specific, reflects the mechanisms of adaptation and maladaptation to chronic hypoxia, and is responsive to change with supplemental oxygen. Advances in research and clinical care will require more "usable" devices that meet the needs of patients and provide value for payers. Optimising oxygen devices will require new technologies with greater portability and greater capacity for oxygen delivery. Registry-based clinical trials may allow measurement of long-term outcomes and identification of patients most likely to benefit from oxygen therapy. Collaborations between patients, clinicians, researchers, payers and industry will be critical to drive this field forward.</p>}},
  author       = {{Holland, Anne E and Krishnan, Jerry A and Lacasse, Yves and Gomes, Humberto and Björklund, Filip and Casaburi, Richard and de Andrade, Joao and Eakin, Michelle N and Hui, David and Jacobs, Susan S and Kawachi, Shohei and Khor, Yet H and Maltais, François and McDonald, Christine F and Musick, Hugh and Ryerson, Chris and Ekström, Magnus}},
  issn         = {{0905-9180}},
  keywords     = {{Humans; Oxygen Inhalation Therapy/trends; Home Care Services/trends; Treatment Outcome; Hypoxia/therapy; Lung/physiopathology; Forecasting; Biomarkers/blood}},
  language     = {{eng}},
  number       = {{181}},
  publisher    = {{European Respiratory Society}},
  series       = {{European respiratory review : an official journal of the European Respiratory Society}},
  title        = {{The future of home oxygen therapy}},
  url          = {{http://dx.doi.org/10.1183/16000617.0144-2026}},
  doi          = {{10.1183/16000617.0144-2026}},
  volume       = {{35}},
  year         = {{2026}},
}